Kangstem Biotech Co., Ltd.
- Biotech or pharma, therapeutic R&D
Kangstem is located in S.Korea. It has developed organoids, completed Phase 3 atopic dermatitis and is conducting on knee osteoarthritis DMOAD Phase 1/2a clinical trial through the unique method of isolating stem cells from umbilical cord blood (UCB-MSC).